A detailed history of Hrt Financial LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Hrt Financial LP holds 210,164 shares of BSX stock, worth $17.8 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
210,164
Previous 6,804 2988.83%
Holding current value
$17.8 Million
Previous $466,000 3372.96%
% of portfolio
0.1%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$67.33 - $77.71 $13.7 Million - $15.8 Million
203,360 Added 2988.83%
210,164 $16.2 Million
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $391,910 - $466,890
6,804 New
6,804 $466,000
Q2 2023

Aug 11, 2023

BUY
$49.72 - $54.64 $22.8 Million - $25 Million
458,116 New
458,116 $24.8 Million
Q4 2022

Feb 10, 2023

BUY
$39.56 - $47.22 $680,432 - $812,184
17,200 New
17,200 $795,000
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $7.27 Million - $9.72 Million
-206,396 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $8.44 Million - $9.31 Million
206,396 New
206,396 $9.14 Million
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $5.55 Million - $6.17 Million
-134,558 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $5.19 Million - $5.95 Million
134,558 New
134,558 $5.75 Million
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $1.13 Million - $1.47 Million
-37,572 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $970,484 - $1.72 Million
37,572 New
37,572 $1.23 Million
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $1.74 Million - $2.08 Million
-45,860 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$40.31 - $43.45 $1.85 Million - $1.99 Million
45,860 New
45,860 $1.87 Million
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $295,966 - $364,384
-8,478 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$32.91 - $40.75 $279,010 - $345,478
8,478 New
8,478 $325,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.